Additionally, between groups of critically ill COVID-19 patients, those on VV-ECMO had a longer length of ICU stay, although this did not reach statistical significance.
← all excerpts
Annexin A1 and Dexamethasone Treatment in Hospitalized COVID-19 Patients: Impact on Disease Recovery and Evidence for an Interplay Between Proresolving Mediators.
1
—
—